Related references
Note: Only part of the references are listed.Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski et al.
NEURO-ONCOLOGY (2016)
Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer
Daniela Achkova et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers
Chang Gon Kim et al.
BRITISH JOURNAL OF CANCER (2016)
First-in-human study of AMG 820, a monoclonal anti-CSF-1R (c-fms) antibody, in patients (pts) with advanced solid tumors
Kyriakos Papadopoulos et al.
CANCER RESEARCH (2016)
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors
Heather L. Gelhorn et al.
CLINICAL THERAPEUTICS (2016)
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik et al.
IMMUNITY (2016)
Tumor macrophages are pivotal constructors of tumor collagenous matrix
Ran Afik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Macrophage Susceptibility to Emactuzumab (RG7155) Treatment
Leon P. Pradel et al.
MOLECULAR CANCER THERAPEUTICS (2016)
TAM receptors regulate multiple features of microglial physiology
Lawrence Fourgeaud et al.
NATURE (2016)
The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis
Ido Amit et al.
NATURE IMMUNOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
Daniela F. Quail et al.
SCIENCE (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
A phase 1a/1b study of FPA008 in combination with nivolumab in patients with selected advanced cancers
Julie Brahmer et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
Rikke B. Holmgaard et al.
EBIOMEDICINE (2016)
Characterization of M1/M2 Tumour-Associated Macrophages (TAMs) and Th1/Th2 Cytokine Profiles in Patients with NSCLC
S. A. Almatroodi et al.
CANCER MICROENVIRONMENT (2016)
18TiP * Phase 1/2a study of double immune suppression blockade by combining a CSF1R inhibitor (pexidartinib/PLX3397) with an anti PD-1 antibody (pembrolizumab) to treat advanced melanoma and other solid tumors
S. Hu-Lieskovan et al.
ANNALS OF ONCOLOGY (2015)
An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma
Bastian von Tresckow et al.
CLINICAL CANCER RESEARCH (2015)
Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy
Mark C. Genovese et al.
JOURNAL OF RHEUMATOLOGY (2015)
CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study
Philippe A. Cassier et al.
LANCET ONCOLOGY (2015)
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
W. D. Tap et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Macrophages and cancer: from mechanisms to therapeutic implications
Renato Ostuni et al.
TRENDS IN IMMUNOLOGY (2015)
The Microsatellite Instable Subset of Colorectal Cancer Is a Particularly Good Candidate for Checkpoint Blockade Immunotherapy
Yanping Xiao et al.
CANCER DISCOVERY (2015)
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
Carola H. Ries et al.
CANCER CELL (2014)
Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy
Stephen Mok et al.
CANCER RESEARCH (2014)
High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma
Martin B. Pedersen et al.
HISTOPATHOLOGY (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice
Calum C. Bain et al.
NATURE IMMUNOLOGY (2014)
Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages
Christoph Schneider et al.
NATURE IMMUNOLOGY (2014)
Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain
Monica R. P. Elmore et al.
NEURON (2014)
CSF-1 Receptor Signaling in Myeloid Cells
E. Richard Stanley et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Distribution and Alteration of Lymphatic Vessels in Knee Joints of Normal and Osteoarthritic Mice
Jixiang Shi et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory Perspectives
Rashmi R. Shah et al.
DRUG SAFETY (2013)
Macrophages promote tumour growth and liver metastasis in an orthotopic syngeneic mouse model of colon cancer
J. Kruse et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2013)
Transcription repressor Bach2 is required for pulmonary surfactant homeostasis and alveolar macrophage function
Atsushi Nakamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF
Martin Guilliams et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
A phase 1 study of ARRY-382, an oral inhibitor of colony-stimulating factor-1 receptor (CSF1R), in patients with advanced or metastatic cancers
Johanna C. Bendell et al.
MOLECULAR CANCER THERAPEUTICS (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
M1 and M2 Macrophages: Oracles of Health and Disease
Charles D. Mills
CRITICAL REVIEWS IN IMMUNOLOGY (2012)
Control of macrophage lineage populations by CSF-1 receptor and GM-CSF in homeostasis and inflammation
Jason C. Lenzo et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Activating Mutations in β-Catenin in Colon Cancer Cells Alter Their Interaction with Macrophages; the Role of Snail
Pawan Kaler et al.
PLOS ONE (2012)
Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
Qiong-wen Zhang et al.
PLOS ONE (2012)
Increased Serum Enzyme Levels Associated with Kupffer Cell Reduction with No Signs of Hepatic or Skeletal Muscle Injury
Zaher A. Radi et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
Absence of Colony Stimulation Factor-1 Receptor Results in Loss of Microglia, Disrupted Brain Development and Olfactory Deficits
Bryna Erblich et al.
PLOS ONE (2011)
Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer
Marco Erreni et al.
CANCER MICROENVIRONMENT (2011)
An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation
Kelli P. A. MacDonald et al.
BLOOD (2010)
The myeloid cells of the central nervous system parenchyma
Richard M. Ransohoff et al.
NATURE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Florent Ginhoux et al.
SCIENCE (2010)
Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
Y. Komohara et al.
JOURNAL OF PATHOLOGY (2008)
Colony-stimulating factors in inflammation and autoimmunity
John A. Hamilton
NATURE REVIEWS IMMUNOLOGY (2008)
Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT)
J. -Y. Blay et al.
ANNALS OF ONCOLOGY (2008)
Pulmonary collectins in innate immunity of the lung
Yoshio Kuroki et al.
CELLULAR MICROBIOLOGY (2007)
Dual role of macrophages in tumor growth and angiogenesis
Chrystelle Lamagna et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses
S. Farzana Hussain et al.
NEURO-ONCOLOGY (2006)
Share Paper
